We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Prescribing for Diabetes in England - 2007/08 - 2017/18 [PAS]Official statistics
- Publication Date:
- 8 Nov 2018
- Geographic Coverage:
- Geographical Granularity:
- Clinical Commissioning Groups
- Date Range:
- 01 Apr 2007 to 31 Mar 2018
Published: 08 November 2018 Prescribing for Diabetes reports on and examines prescribing trends on medicines prescribed in primary care in England for the treatment and monitoring of diabetes during the period April 2007 to March 2018.
Prescribing for Diabetes reports on and examines prescribing trends on medicines prescribed in primary care in England for the treatment and monitoring of diabetes during the period April 2007 to March 2018.
Diabetes is a high profile clinical area, as the prevalence is increasing and costs associated with treating patients with diabetes are also increasing.
• Drugs used in diabetes (British National Formulary (BNF) section 6.1) now make up 11.4 per cent of total primary care net ingredient costs (NIC) and 4.9 per cent of prescription items (See Figure 1).
• In the financial year 2017/18 there were 53.4 million items prescribed for diabetes at a total net ingredient cost of £1,012.4 million. Up by 22.6 million prescription items and £421.7 million since 2007/08.
• Antidiabetic drugs (BNF section 6.1.2) make up 47.1 per cent of the total net ingredient cost of drugs used in diabetes and accounts for 72.6 per cent of prescription items for all diabetes prescribing.
ePACT, QOF, NDA